A novel phosphorylation site of N-methyl-d-aspartate receptor GluN2B at S1284 is regulated by Cdk5 in neuronal ischemia

Experimental Neurology

Volumn 271, Issue , 2015, Pages 251-258

  Lu, Wen ^a   Ai, Heng ^a   Peng, Lin ^a   Wang, Jie jie ^a   Zhang, Bin ^a   Liu, Xiao ^a   Luo, Jian hong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cdk5; GluN2B; Ischemia; LTP; NMDA receptor; S1284

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; SERINE; CENTRAL STIMULANT AGENT; GLUCOSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR; PICROTOXIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CARBOXY TERMINAL SEQUENCE; CONDITIONING; CONTEXTUAL FEAR CONDITIONING; CONTROLLED STUDY; CYTOPLASM; EMBRYO; ENZYME ACTIVATION; FEMALE; HIPPOCAMPAL NEURONAL CULTURE; ISCHEMIA; LONG TERM POTENTIATION; MALE; MOUSE; NEURONAL ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; ANIMAL; ANIMAL EMBRYO; ANOXIA; CAROTID ARTERY DISEASE; CELL CULTURE; CYTOLOGY; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; POSTSYNAPTIC DENSITY;

ANIMALS; ANOXIA; CAROTID ARTERY DISEASES; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLIN-DEPENDENT KINASE 5; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; GLUCOSE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; NEURONS; PHOSPHORYLATION; PICROTOXIN; POST-SYNAPTIC DENSITY; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE;

EID: 84934977870     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.06.016     Document Type: Article

References (45)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor - PSD-95 protein interactions. Science 2002, 298:846-850.
2. Ai H., Yang W., Ye M., Lu W., Yao L., Luo J.H. Differential regulation of AMPA receptor GluA1 phosphorylation at serine 831 and 845 associated with activation of NMDA receptor subpopulations. Neurosci. Lett. 2011, 497:94-98.
3. Ai H., Lu W., Ye M., Yang W. Synaptic non-GluN2B-containing NMDA receptors regulate tyrosine phosphorylation of GluN2B 1472 tyrosine site in rat brain slices. Neurosci. Bull. 2013, 29:614-620.
4. Al-Hallaq R.A., Conrads T.P., Veenstra T.D., Wenthold R.J. NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J. Neurosci. 2007, 27:8334-8343.
5. Angelo M., Plattner F., Giese K.P. Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. J. Neurochem. 2006, 99:353-370.
6. Boehm J., Kang M.G., Johnson R.C., Esteban J., Huganir R.L., Malinow R. Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron 2006, 51:213-225.
7. Cao M., Xu J., Shen C., Kam C., Huganir R.L., Xia J. PICK1-ICA69 heteromeric BAR domain complex regulates synaptic targeting and surface expression of AMPA receptors. J. Neurosci. 2007, 27:12945-12956.
8. Chen B.S., Roche K.W. Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53:362-368.
9. Cheung Z.H., Ip N.Y. The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2007, 2:949-957.
10. Cull-Candy S.G., Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE 2004, re16.
11. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 2001, 11:327-335.
12. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
13. Fan J., Gladding C.M., Wang L., Zhang L.Y., Kaufman A.M., Milnerwood A.J., Raymond L.A. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease. Neurobiol. Dis. 2012, 45:999-1009.
14. Fowler S.W., Chiang A.C., Savjani R.R., Larson M.E., Sherman M.A., Schuler D.R., Cirrito J.R., Lesne S.E., Jankowsky J.L. Genetic modulation of soluble Abeta rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. J. Neurosci. 2014, 34:7871-7885.
15. Fu W.Y., Chen Y., Sahin M., Zhao X.S., Shi L., Bikoff J.B., Lai K.O., Yung W.H., Fu A.K., Greenberg M.E., Ip N.Y. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat. Neurosci. 2007, 10:67-76.
16. Goebel-Goody S.M., Davies K.D., Alvestad Linger R.M., Freund R.K., Browning M.D. Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience 2009, 158:1446-1459.
17. Hawasli A.H., Benavides D.R., Nguyen C., Kansy J.W., Hayashi K., Chambon P., Greengard P., Powell C.M., Cooper D.C., Bibb J.A. Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci. 2007, 10:880-886.
18. Hill M.D., Martin R.H., Mikulis D., Wong J.H., Silver F.L., Terbrugge K.G., Milot G., Clark W.M., Macdonald R.L., Kelly M.E., Boulton M., Fleetwood I., McDougall C., Gunnarsson T., Chow M., Lum C., Dodd R., Poublanc J., Krings T., Demchuk A.M., Goyal M., Anderson R., Bishop J., Garman D., Tymianski M. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2012, 11:942-950.
19. Jiang X., Knox R., Pathipati P., Ferriero D. Developmental localization of NMDA receptors, Src and MAP kinases in mouse brain. Neurosci. Lett. 2011, 503:215-219.
20. Kohr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 2006, 326:439-446.
21. Li B.S., Sun M.K., Zhang L., Takahashi S., Ma W., Vinade L., Kulkarni A.B., Brady R.O., Pant H.C. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12742-12747.
22. Menn B., Bach S., Blevins T.L., Campbell M., Meijer L., Timsit S. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS One 2010, 5:e12117.
23. Meyer D.A., Torres-Altoro M.I., Tan Z., Tozzi A., Di Filippo M., DiNapoli V., Plattner F., Kansy J.W., Benkovic S.A., Huber J.D., Miller D.B., Greengard P., Calabresi P., Rosen C.L., Bibb J.A. Ischemic stroke injury is mediated by aberrant Cdk5. J. Neurosci. 2014, 34:8259-8267.
24. Morabito M.A., Sheng M., Tsai L.H. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 2004, 24:865-876.
25. Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B., Panse C., Schlapbach R., Mansuy I.M. Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol. Cell. Proteomics 2007, 6:283-293.
26. Murphy J.A., Stein I.S., Lau C.G., Peixoto R.T., Aman T.K., Kaneko N., Aromolaran K., Saulnier J.L., Popescu G.K., Sabatini B.L., Hell J.W., Zukin R.S. Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines. J. Neurosci. 2014, 34:869-879.
27. Otmakhov N., Khibnik L., Otmakhova N., Carpenter S., Riahi S., Asrican B., Lisman J. Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. J. Neurophysiol. 2004, 91:1955-1962.
28. Pacchioni A.M., Vallone J., Worley P.F., Kalivas P.W. Neuronal pentraxins modulate cocaine-induced neuroadaptations. J. Pharmacol. Exp. Ther. 2009, 328:183-192.
29. Paoletti P., Bellone C., Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 2013, 14:383-400.
30. Park Y., Luo T., Zhang F., Liu C., Bramlett H.M., Dietrich W.D., Hu B. Downregulation of Src-kinase and glutamate-receptor phosphorylation after traumatic brain injury. J. Cereb. Blood Flow Metab. 2013, 33:1642-1649.
31. Plattner F., Hernandez A., Kistler T.M., Pozo K., Zhong P., Yuen E.Y., Tan C., Hawasli A.H., Cooke S.F., Nishi A., Guo A., Wiederhold T., Yan Z., Bibb J.A. Memory enhancement by targeting Cdk5 regulation of NR2B. Neuron 2014, 81:1070-1083.
32. Qiu S., Chen T., Koga K., Guo Y.Y., Xu H., Song Q., Wang J.J., Descalzi G., Kaang B.K., Luo J.H., Zhuo M., Zhao M.G. An increase in synaptic NMDA receptors in the insular cortex contributes to neuropathic pain. Sci. Signal. 2013, 6:ra34.
33. Salter M.W., Kalia L.V. Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 2004, 5:317-328.
34. Sanz-Clemente A., Matta J.A., Isaac J.T., Roche K.W. Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors. Neuron 2010, 67:984-996.
35. Su S.C., Tsai L.H. Cyclin-dependent kinases in brain development and disease. Annu. Rev. Cell Dev. Biol. 2011, 27:465-491.
36. Szepesi Z., Hosy E., Ruszczycki B., Bijata M., Pyskaty M., Bikbaev A., Heine M., Choquet D., Kaczmarek L., Wlodarczyk J. Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors. PLoS One 2014, 9:e98274.
37. Takasu M.A., Dalva M.B., Zigmond R.E., Greenberg M.E. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 2002, 295:491-495.
38. Trinidad J.C., Thalhammer A., Specht C.G., Lynn A.J., Baker P.R., Schoepfer R., Burlingame A.L. Quantitative analysis of synaptic phosphorylation and protein expression. Mol. Cell. Proteomics 2008, 7:684-696.
39. Wang J., Liu S., Fu Y., Wang J.H., Lu Y. Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 2003, 6:1039-1047.
40. Wang Y.B., Wang J.J., Wang S.H., Liu S.S., Cao J.Y., Li X.M., Qiu S., Luo J.H. Adaptor protein APPL1 couples synaptic NMDA receptor with neuronal prosurvival phosphatidylinositol 3-kinase/Akt pathway. J. Neurosci. 2012, 32:11919-11929.
41. Wenzel A., Fritschy J.M., Mohler H., Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 1997, 68:469-478.
42. Yan H., Zhang X., Hu W., Ma J., Hou W., Wang X., Gao J., Shen Y., Lv J., Ohtsu H., Han F., Wang G., Chen Z. Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms. Nat. Commun. 2014, 5:3334.
43. Ye M., Yang W., Ainscough J.F., Hu X.P., Li X., Sedo A., Zhang X.H., Zhang X., Chen Z., Li X.M., Beech D.J., Sivaprasadarao A., Luo J.H., Jiang L.H. TRPM2 channel deficiency prevents delayed cytosolic Zn2+ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis. 2014, 5:e1541.
44. Zhang S., Edelmann L., Liu J., Crandall J.E., Morabito M.A. Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors. J. Neurosci. 2008, 28:415-424.
45. Zhang F., Guo A., Liu C., Comb M., Hu B. Phosphorylation and assembly of glutamate receptors after brain ischemia. Stroke 2013, 44:170-176.